JP2009514899A5 - - Google Patents

Download PDF

Info

Publication number
JP2009514899A5
JP2009514899A5 JP2008539136A JP2008539136A JP2009514899A5 JP 2009514899 A5 JP2009514899 A5 JP 2009514899A5 JP 2008539136 A JP2008539136 A JP 2008539136A JP 2008539136 A JP2008539136 A JP 2008539136A JP 2009514899 A5 JP2009514899 A5 JP 2009514899A5
Authority
JP
Japan
Prior art keywords
pyridin
phenyl
amino
compound according
ylthieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008539136A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009514899A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/060145 external-priority patent/WO2007056625A2/en
Publication of JP2009514899A publication Critical patent/JP2009514899A/ja
Publication of JP2009514899A5 publication Critical patent/JP2009514899A5/ja
Pending legal-status Critical Current

Links

JP2008539136A 2005-11-04 2006-10-23 チエノピリジンB−Rafキナーゼ阻害剤 Pending JP2009514899A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73356605P 2005-11-04 2005-11-04
PCT/US2006/060145 WO2007056625A2 (en) 2005-11-04 2006-10-23 Thienopyridine b-raf kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2009514899A JP2009514899A (ja) 2009-04-09
JP2009514899A5 true JP2009514899A5 (enExample) 2009-07-16

Family

ID=38024028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008539136A Pending JP2009514899A (ja) 2005-11-04 2006-10-23 チエノピリジンB−Rafキナーゼ阻害剤

Country Status (4)

Country Link
US (1) US20080255184A1 (enExample)
EP (1) EP1951728A4 (enExample)
JP (1) JP2009514899A (enExample)
WO (1) WO2007056625A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202363B2 (en) 2003-07-24 2007-04-10 Abbott Laboratories Thienopyridine and furopyridine kinase inhibitors
AR070317A1 (es) * 2008-02-06 2010-03-31 Osi Pharm Inc Furo (3,2-c) piridina y tieno (3,2-c) piridinas
EP2265574A1 (en) * 2008-02-29 2010-12-29 Array Biopharma, Inc. N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
WO2009111277A1 (en) * 2008-02-29 2009-09-11 Array Biopharma Inc. Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors
EP2265610B1 (en) * 2008-02-29 2012-12-12 Array Biopharma, Inc. Pyrazole [3, 4-b]pyridine raf inhibitors
CN102015707A (zh) * 2008-02-29 2011-04-13 阵列生物制药公司 Raf抑制剂化合物及其使用方法
KR101639642B1 (ko) 2008-12-05 2016-07-14 애브비 바하마스 리미티드 암 치료에 사용하기 위한 키나제 억제제로서의 티에노[3,2-c]피리딘 유도체
CA2794153C (en) 2010-03-25 2018-01-02 Glaxosmithkline Llc Substituted indoline derivatives as perk inhibitors
UY33288A (es) * 2010-03-25 2011-10-31 Glaxosmithkline Llc Derivados de indolina inhibidores de la proteina quinasa r del reticulo endoplasmatico
WO2013012909A1 (en) 2011-07-20 2013-01-24 Abbott Laboratories Kinase inhibitor with improved aqueous solubility
US9408885B2 (en) 2011-12-01 2016-08-09 Vib Vzw Combinations of therapeutic agents for treating melanoma
US11471538B2 (en) 2017-02-10 2022-10-18 INSERM (Institut National de la Santéet de la Recherche Medicale) Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the MAPK pathway
EP3732285A1 (en) 2017-12-28 2020-11-04 Tract Pharmaceuticals, Inc. Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
CN119638639A (zh) * 2024-12-10 2025-03-18 中国药科大学 具有抗细胞坏死性凋亡活性的联芳基类化合物及其衍生物与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0121490D0 (en) * 2001-09-05 2001-10-24 Smithkline Beecham Plc Ciompounds
US7144885B2 (en) * 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
US20050020619A1 (en) * 2003-07-24 2005-01-27 Patrick Betschmann Thienopyridine kinase inhibitors
US20050026944A1 (en) * 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors
US7202363B2 (en) * 2003-07-24 2007-04-10 Abbott Laboratories Thienopyridine and furopyridine kinase inhibitors
AR045944A1 (es) * 2003-09-24 2005-11-16 Novartis Ag Derivados de isoquinolina 1.4-disustituidas
DE10351436A1 (de) * 2003-11-04 2005-06-09 Merck Patent Gmbh Verwendung von Thienopyrimidinen

Similar Documents

Publication Publication Date Title
CN103121996B (zh) 用作mek抑制剂的杂芳基取代的芳基氨基吡啶衍生物
JP2021534124A5 (enExample)
JP2015503529A5 (enExample)
JP2007535551A5 (enExample)
JP2006524222A5 (enExample)
JP2010530438A5 (enExample)
JP2004504301A5 (enExample)
JP2010506918A5 (enExample)
JP2005513123A5 (enExample)
JP2006515858A5 (enExample)
JP2014506599A5 (enExample)
JP2005508960A5 (enExample)
JP6319436B2 (ja) 2−アシルアミノチアゾール誘導体またはその塩
TW200524575A (en) Biaryl linked hydroxamates: preparation and pharmaceutical applications
JP2004506632A5 (enExample)
JP2016513660A5 (enExample)
MX2013010276A (es) Derivados de fluoro-piridinona utiles como agentes antibacterianos.
JP2013505969A5 (enExample)
CA2437409A1 (en) Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
RU2012129737A (ru) Замещенные бензамидные производные
JP2022549222A5 (enExample)
JP2005508967A5 (enExample)
WO2011021209A1 (en) Histone deacetylase inhibitors
CA2601508A1 (en) Cyclopropanecarboxamide derivatives
BR112020027064A2 (pt) derivados de quinazolina do tipo éter biarílico